{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
<< Back to Michigan Medicine
Client Logo
  • Sign In
  • Live Courses
  • RSS
  • On Demand
  • Planning Guide
  • About
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Welcome. Please use the same credentials each time you sign in to avoid creating duplicate accounts. For account support, please submit a ticket.

***

  1. University of Michigan Campus and AMC: Sign in with your uniqname and password.

  2. UM-Health Sparrow and UM-Health West:
  3. > NEW accounts: Sign in with your @uofmhealth.org email and password.
    > EXISTING accounts: Sign in with your existing email and password. If you are still using your previous UM Health-West or UM Health-Sparrow email, please update the email address on file to your @uofmhealth.org email.

  4. If you are external to the University of Michigan, please sign in with your existing account username and password. Or create a new account after clicking the "External Sign In" button below.
AMC and Campus Sign In
Sparrow, West, External Sign In
Enter your email and password to login:

*
*
Login

New to MiCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • BSN
  • BSN, RN
  • CNM
  • CRNA
  • DDS
  • DMD
  • DO
  • DPM
  • DPT
  • JD
  • LCSW
  • LPN
  • MA
  • MBBS
  • MD
  • MD, MPH
  • MD, PhD
  • MHA
  • MPH
  • MS
  • MSN
  • MSN, NP
  • MSN, RN
  • MSW
  • None
  • NP
  • OD
  • Other
  • PA
  • PharmD
  • PhD
  • PsyD
  • PT
  • RN
Degree is required
Please enter your degree:
You must enter a degree

Profession is required

User Agreement

This form collects name, email address and other contact information so our support team can communicate and provide assistance. Please check our Privacy Policy to see how we protect and manage submitted data. By creating a MiCME powered by CloudCME account, you agree to have your contact information collected via this form. You must also consent below.


You must agree to the terms and conditions before registering.




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Michigan Medicine Annual Hematologic Malignancies Symposium

  • Overview
  • Register
  • Faculty
  • Schedule
Add to Calendar Michigan Medicine Annual Hematologic Malignancies Symposium 10/10/2026 9:00:00 AM 10/10/2026 3:30:00 PM America/New_York For More Details: https://umich.cloud-cme.com/course/courseoverview?EID=82377 Description: The University of Michigan Rogel Cancer Center (UMRCC) is an NCI-designated comprehensive cancer center with a history of excellence in cancer care, education, and research. The UMRCC catchment area includes the entire State of Michigan, its ˜10M residents, and ˜750 community medical oncologists. Join UMRCC for the Michigan Medicine Annual Hematologic Malignancies Symposium Saturday, October 10, 2026... The Amway Grand Plaza false MM/DD/YYYY


Date & Location
Saturday, October 10, 2026, 9:00 AM - 3:30 PM ET, The Amway Grand Plaza, Grand Rapids, MI

Target Audience
Specialties - Hematology/Oncology, Internal Medicine
Professions - House Officer, Nurse, Nurse Practitioner, Pharmacist, Physician, Physician Assistant, Physician Fellow, Physician Resident

Credits
AMA PRA Category 1 Credits™ (4.50 hours), Non-Physician Attendance (4.50 hours)

Overview
The University of Michigan Rogel Cancer Center (UMRCC) is an NCI-designated comprehensive cancer center with a history of excellence in cancer care, education, and research. The UMRCC catchment area includes the entire State of Michigan, its ˜10M residents, and ˜750 community medical oncologists. Join UMRCC for the Michigan Medicine Annual Hematologic Malignancies Symposium Saturday, October 10, 2026.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Utilize the most current, state of the art updates in the diagnosis, risk stratification, and treatment of all hematologic malignancies.
  2. Routinely obtain and apply information about clinical trials designed specifically to treat Hematologic Malignancies.
  3. Successfully enroll patients to the ground breaking and often life saving clinical trials.

Accreditation

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
AMA PRA Category 1 
The University of Michigan Medical School designates this Live Activity for a maximum of 4.50 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Additional Information

Accessibility Statement
The University of Michigan Medical School is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Activity Coordinator.

Questions? Please contact Jennifer Fossum.



Keywords: LIVEAMAFeatured

Mitigation of Relevant Financial Relationships

The University of Michigan Medical School adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a CE activity, including faculty, planners, or others are required to disclose all relevant financial relationships with ineligible entities. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Erica LEIGH Campagnaro, MD
Rogel Cancer Center
Educational Co-Planner, Faculty
Nothing to disclose
Ryan A Wilcox, MD, PhD
University of Michigan
Educational Planner, Faculty
Consulting Fee-Acrotech (Relationship has ended)
Patrick Burke, MD
Michigan Medicine/University of Michigan
Faculty
Shannon Ann Carty, MD
University of Michigan
Faculty
Michael Deininger, MD, PhD
University of Michigan
Faculty
Nothing to disclose
Marcus Geer, MD
Michigan Medicine, Department of Internal Medicine
Faculty
Jolanta Grembecka, PhD
Faculty
Yasmin H Karimi, MD
University of Michigan
Faculty
Jonathan D. Licht, MD
President and Chief Scientific Officer
Van Andle Institute
Faculty
Kamran Mirza, MD, PhD
Clinical Professor
Michigan Medicine
Faculty
Nothing to disclose
Carlos Murga-Zamalloa, MD
Faculty
Kristen Pettit, MD
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck (Any division) (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Takeda Pharmaceuticals (Any division) (Relationship has ended)
Matthew Pianko, MD
Faculty
Paid consultant-Janssen (Any division)|Paid consultant-Pfizer (Any division)|Advisor-Sanofi S.A. (Relationship has ended)|Grant or research support-Sanofi S.A.|Grant or research support-Bristol-Myers Squibb Company|Paid consultant-Bristol-Myers Squibb Company|Grant or research support-Pfizer (Any division)|Grant or research support-Janssen (Any division)|Grant or research support-AbbVie (Any division)|Paid consultant-GlaxoSmithKline|Grant or research support-AstraZeneca (Any division)|Consulting Fee-Regeneron Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Regeneron Pharmaceuticals, Inc.
moshe talpaz, MD
University of Michigan Michigan Medicine
Faculty
Advisor-Sumitomo (Relationship has ended)|Grant or research support-Bristol-Myers Squibb Company (Relationship has ended)|Advisor-Incyte Corporation Incyte Corporation (Relationship has ended)|Advisor-Novartis Corporation Pharmaceuticals (Relationship has ended)
Jonathan Weiss, MD
University of Michigan
Faculty
Nothing to disclose
Jeffrey Allan Zonder, MD
Karmanos Cancer Institute
Faculty

Saturday, October 10, 2026

Keynote: How the molecular biology of multiple myeloma informs current and future therapy
9:00AM - 10:00AM
Jonathan D. Licht, MD (Speaker)
Session A
BREAK
10:00AM - 10:15AM

Immunotherapy for myeloma debate : CAR-T or T-cell redirection therapy? - Panel Discussion
10:15AM - 10:40AM
Matthew Pianko, MD (Panelist)
Marcus Geer, MD (Panelist)
Session B
When CHOP doesn't cut it: Rare T-cell Lymphomas
10:15AM - 10:40AM
Ryan A Wilcox, MD, PhD (Panelist)
Shannon Ann Carty, MD (Panelist)
Jonathan Weiss, MD (Panelist)
Session A
PTCL, NOS Classification and Treatment
10:40AM - 11:05AM
Ryan A Wilcox, MD, PhD (Panelist)
Carlos Murga-Zamalloa, MD (Panelist)

Updates in light chain AL amyloidosis
10:40AM - 11:05AM
Jeffrey Allan Zonder, MD (Speaker)
Session B
Case-based discussion : challenges in relapsed/refractory myeloma - Panel Discussion
11:05AM - 11:30AM
Matthew Pianko, MD (Panelist)
Jeffrey Allan Zonder, MD (Panelist)
Erica LEIGH Campagnaro, MD (Panelist)
Session B
T-ALL Update: Classification and Treatment
11:05AM - 11:30AM
Patrick Burke, MD

Lunch - North Concourse // Optional Product Theaters - Pearl Room, Emerald Rooms A and B
11:30AM - 1:00PM

Keynote Address - Menin inhibitors as a treatment for AML: from discovery to FDA approval and beyond - Senator Vandenberg Room
1:00PM - 2:00PM
Jolanta Grembecka, PhD (Speaker)

*BREAK*
2:00PM - 2:15PM

Session A (B-cell Lymphomas) Lymphoma lightning rounds: Case-based discussions and debates. Is there a role for ctDNA and MRD assessments in aggressive lymphomas? Updates: Bispecific antibodies and “chemo free” regimens. Optimal frontline and second-line regimens in indolent lymphomas
2:15PM - 3:30PM
Jonathan Weiss, MD (Panelist)
Yasmin H Karimi, MD (Panelist)

Session B (Myeloid leukemias) The clinical experience with menin inhibitors
2:15PM - 3:30PM
Patrick Burke, MD (Moderator)
Kristen Pettit, MD (Panelist)
moshe talpaz, MD (Panelist)
Michael Deininger, MD, PhD (Panelist)
Kamran Mirza, MD, PhD (Panelist)

Office of Continuing Medical Education and Lifelong Learning
1600 Huron Parkway Building #400
Ann Arbor, MI 48109-2800

©1995-2024 Regents of the University of Michigan Privacy Policy | Disclaimer | Non-Discrimination
ACCME Accreditation with Commendation

Powered By CloudCME